NEO Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | Dieter Cynthia J | officer: Chief Accounting Officer | 29,765 | F-InKind | D | 117 | 0.00 | 0.00 |
| 2023-03-01 | Dieter Cynthia J | officer: Chief Accounting Officer | 29,882 | F-InKind | D | 880 | 0.00 | 0.00 |
| 2023-01-01 | Harris Melody | officer: President, Enterprise Ops | 201,613 | A-Award | A | 201,613 | 9.24 | 1,862,904.12 |
| 2023-01-01 | Harris Melody | officer: President, Enterprise Ops | 108,225 | A-Award | A | 108,225 | 0.00 | 0.00 |
| 2022-12-31 | Sikri Vishal | officer: President, Pharma Services | 148,680 | L-Small | A | 225 | 7.04 | 1,584.00 |
| 2022-12-31 | Dieter Cynthia J | officer: Chief Accounting Officer | 30,762 | F-InKind | D | 959 | 0.00 | 0.00 |
| 2022-12-05 | Sherman Jeffrey Scott | officer: Chief Financial Officer | 249,169 | A-Award | A | 249,169 | 11.62 | 2,895,343.78 |
| 2022-12-05 | Sherman Jeffrey Scott | officer: Chief Financial Officer | 133,809 | A-Award | A | 89,206 | 0.00 | 0.00 |
| 2022-12-05 | Sherman Jeffrey Scott | officer: Chief Financial Officer | 44,603 | A-Award | A | 44,603 | 0.00 | 0.00 |
| 2022-12-01 | Stone Warren | officer: President, Clinical Services | 166,113 | A-Award | A | 166,113 | 11.21 | 1,862,126.73 |
| 2022-12-01 | Stone Warren | officer: President, Clinical Services | 89,206 | A-Award | A | 89,206 | 0.00 | 0.00 |
| 2022-11-03 | Perez David Brian | director | 9,730 | A-Award | A | 9,730 | 7.34 | 71,418.20 |
| 2022-11-03 | Perez David Brian | director | 10,300 | A-Award | A | 10,300 | 0.00 | 0.00 |
| 2022-11-01 | Dieter Cynthia J | officer: Chief Accounting Officer | 31,721 | A-Award | A | 13,141 | 0.00 | 0.00 |
| 2022-08-15 | Smith Christopher M | officer: Chief Executive Officer | 694,444 | A-Award | A | 694,444 | 12.62 | 8,763,883.28 |
| 2022-08-15 | Smith Christopher M | officer: Chief Executive Officer | 602,219 | A-Award | A | 265,452 | 0.00 | 0.00 |
| 2022-08-15 | Smith Christopher M | officer: Chief Executive Officer | 336,767 | A-Award | A | 336,767 | 0.00 | 0.00 |
| 2022-08-01 | Kulkarni Shashikant | officer: President of Lab Operations | 51,653 | A-Award | A | 51,653 | 10.12 | 522,728.36 |
| 2022-08-01 | Kulkarni Shashikant | officer: President of Lab Operations | 65,856 | A-Award | A | 24,704 | 0.00 | 0.00 |
| 2022-08-01 | Sholehvar David | officer: President, Clinical Services | 25,826 | A-Award | A | 25,826 | 10.12 | 261,359.12 |
| 2022-08-01 | Sholehvar David | officer: President, Clinical Services | 43,216 | A-Award | A | 12,352 | 0.00 | 0.00 |
| 2022-06-22 | Dieter Cynthia J | officer: Chief Accounting Officer | 18,580 | F-InKind | D | 57 | 0.00 | 0.00 |
| 2022-06-10 | TETRAULT LYNN A. | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | TETRAULT LYNN A. | director | 54,667 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-10 | Daly David | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | Daly David | director | 21,335 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-10 | Stahler Rachel A | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | Stahler Rachel A | director | 21,335 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-10 | HANNAH ALISON L. | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | HANNAH ALISON L. | director | 107,433 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-10 | CROWTHER BRUCE K | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | CROWTHER BRUCE K | director | 65,120 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-10 | KANOVSKY STEPHEN M | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | KANOVSKY STEPHEN M | director | 24,754 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-10 | Kelly Michael Aaron | director | 13,882 | A-Award | A | 13,882 | 8.10 | 112,444.20 |
| 2022-06-10 | Kelly Michael Aaron | director | 20,419 | A-Award | A | 15,556 | 0.00 | 0.00 |
| 2022-06-01 | Sikri Vishal | officer: President and CCO, Inivata | 319,112 | A-Award | A | 319,112 | 8.42 | 2,686,923.04 |
| 2022-06-01 | Sikri Vishal | officer: President and CCO, Inivata | 148,455 | A-Award | A | 148,455 | 0.00 | 0.00 |
| 2022-05-18 | TETRAULT LYNN A. | director | 0 | M-Exempt | D | 3,334 | 7.27 | 24,238.18 |
| 2022-05-18 | TETRAULT LYNN A. | director | 39,111 | M-Exempt | A | 3,334 | 7.27 | 24,238.18 |
| 2022-04-28 | Bonello William | officer: Chief Financial Officer | 0 | M-Exempt | D | 5,727 | 7.52 | 43,067.04 |
| 2022-04-28 | Bonello William | officer: Chief Financial Officer | 191,548 | M-Exempt | A | 5,727 | 7.52 | 43,067.04 |
| 2022-04-01 | Brown Douglas Matthew | officer: Chief Strategy Officer | 158,684 | A-Award | A | 82,305 | 0.00 | 0.00 |
| 2022-04-01 | Sholehvar David | officer: President, Clinical Services | 66,372 | A-Award | A | 66,372 | 12.15 | 806,419.80 |
| 2022-04-01 | Sholehvar David | officer: President, Clinical Services | 30,864 | A-Award | A | 30,864 | 0.00 | 0.00 |
| 2022-04-01 | Bonello William | officer: Chief Financial Officer | 185,821 | A-Award | A | 82,305 | 0.00 | 0.00 |
| 2022-03-08 | Bonello William | officer: Chief Financial Officer | 5,727 | M-Exempt | D | 5,000 | 7.52 | 37,600.00 |
| 2022-03-08 | Bonello William | officer: Chief Financial Officer | 103,516 | M-Exempt | A | 5,000 | 7.52 | 37,600.00 |
| 2022-03-07 | Bonello William | officer: Chief Financial Officer | 98,516 | S-Sale | D | 3,209 | 18.29 | 58,692.61 |
| 2022-03-02 | Brown Douglas Matthew | officer: Chief Strategy Officer | 85,519 | A-Award | D | 85,519 | 21.41 | 1,830,961.79 |
| 2022-03-02 | Brown Douglas Matthew | officer: Chief Strategy Officer | 76,379 | F-InKind | D | 867 | 0.00 | 0.00 |
| 2022-03-02 | Bonello William | officer: Chief Financial Officer | 99,772 | A-Award | D | 99,772 | 21.41 | 2,136,118.52 |
| 2022-03-02 | Bonello William | officer: Chief Financial Officer | 101,725 | F-InKind | D | 620 | 0.00 | 0.00 |
| 2022-03-02 | CARDOZA GEORGE | officer: President & COO, Lab Ops | 244,157 | F-InKind | D | 839 | 0.00 | 0.00 |
| 2022-03-02 | Dieter Cynthia J | officer: Chief Accounting Officer | 22,805 | A-Award | D | 22,805 | 21.41 | 488,255.05 |
| 2022-03-02 | Dieter Cynthia J | officer: Chief Accounting Officer | 18,637 | F-InKind | D | 137 | 0.00 | 0.00 |
| 2022-03-01 | Gilbert Halley E | officer: Chief Legal Officer | 102,623 | A-Award | A | 102,623 | 21.41 | 2,197,158.43 |
| 2022-03-01 | Gilbert Halley E | officer: Chief Legal Officer | 147,396 | A-Award | A | 42,036 | 0.00 | 0.00 |
| 2022-03-01 | Mallon Mark | director, officer: Chief Executive Officer | 347,777 | A-Award | A | 347,777 | 21.41 | 7,445,905.57 |
| 2022-03-01 | Mallon Mark | director, officer: Chief Executive Officer | 368,051 | A-Award | A | 142,457 | 0.00 | 0.00 |
| 2022-03-01 | Wallar Gina M | officer: President, Pharma Services | 28,506 | A-Award | A | 28,506 | 21.41 | 610,313.46 |
| 2022-03-01 | Wallar Gina M | officer: President, Pharma Services | 33,443 | A-Award | A | 11,677 | 0.00 | 0.00 |
| 2022-03-01 | Brown Douglas Matthew | officer: Chief Strategy Officer | 77,246 | A-Award | A | 35,030 | 0.00 | 0.00 |
| 2022-03-01 | Bonello William | officer: Chief Financial Officer | 102,345 | F-InKind | D | 397 | 0.00 | 0.00 |
| 2022-03-01 | Bonello William | officer: Chief Financial Officer | 102,742 | A-Award | A | 40,869 | 0.00 | 0.00 |
| 2022-03-01 | CARDOZA GEORGE | officer: President & COO, Lab Ops | 244,996 | F-InKind | D | 503 | 0.00 | 0.00 |
| 2022-03-01 | Dieter Cynthia J | officer: Chief Accounting Officer | 18,774 | A-Award | A | 9,341 | 0.00 | 0.00 |
| 2022-01-11 | McKenzie Kathryn B | officer: Chief Sustainability/Risk Ofcr | 17,900 | M-Exempt | D | 2,100 | 9.07 | 19,047.00 |
| 2022-01-11 | McKenzie Kathryn B | officer: Chief Sustainability/Risk Ofcr | 49,361 | M-Exempt | A | 2,100 | 9.07 | 19,047.00 |
| 2021-12-31 | Wallar Gina M | officer: President, Pharma Services | 21,662 | L-Small | A | 363 | 35.28 | 12,806.64 |
| 2021-12-31 | Gilbert Halley E | officer: Chief Legal Officer | 105,263 | L-Small | A | 177 | 31.30 | 5,540.10 |
| 2021-12-30 | Morris Clive | officer: President of Inivata | 41,280 | A-Award | A | 30,572 | 0.00 | 0.00 |
| 2021-12-30 | Wallar Gina M | officer: President, Pharma Services | 21,299 | A-Award | A | 15,286 | 0.00 | 0.00 |
| 2021-12-30 | Mallon Mark | director, officer: Chief Executive Officer | 225,594 | A-Award | A | 152,858 | 0.00 | 0.00 |
| 2021-12-30 | Brown Douglas Matthew | officer: Chief Strategy Officer | 42,216 | A-Award | A | 30,572 | 0.00 | 0.00 |
| 2021-12-30 | Gilbert Halley E | officer: Chief Legal Officer | 105,086 | A-Award | A | 45,858 | 0.00 | 0.00 |
| 2021-12-30 | Dieter Cynthia J | officer: Chief Accounting Officer | 9,433 | A-Award | A | 7,643 | 0.00 | 0.00 |
| 2021-12-30 | BALLIET JENNIFER | officer: VP and Chief Culture Officer | 48,615 | A-Award | A | 21,400 | 0.00 | 0.00 |
| 2021-12-30 | Bonello William | officer: President, Informatics | 61,873 | A-Award | A | 21,400 | 0.00 | 0.00 |
| 2021-12-30 | McKenzie Kathryn B | officer: Chief Financial Officer | 47,261 | A-Award | A | 30,572 | 0.00 | 0.00 |
| 2021-12-30 | CARDOZA GEORGE | officer: President & COO, Lab Ops | 245,499 | A-Award | A | 61,143 | 0.00 | 0.00 |
| 2021-12-22 | Johnson Kevin C | director | 0 | M-Exempt | D | 3,334 | 7.27 | 24,238.18 |
| 2021-12-22 | Johnson Kevin C | director | 37,398 | M-Exempt | A | 3,334 | 7.27 | 24,238.18 |
| 2021-12-22 | McKenzie Kathryn B | officer: Chief Financial Officer | 20,000 | M-Exempt | D | 5,000 | 9.07 | 45,350.00 |
| 2021-12-22 | McKenzie Kathryn B | officer: Chief Financial Officer | 16,689 | M-Exempt | A | 5,000 | 9.07 | 45,350.00 |
| 2021-12-21 | McKenzie Kathryn B | officer: Chief Financial Officer | 11,689 | S-Sale | D | 1,846 | 35.00 | 64,610.00 |
| 2021-12-06 | Mallon Mark | director, officer: Chief Executive Officer | 72,736 | P-Purchase | A | 17,000 | 30.63 | 520,710.00 |
| 2021-11-30 | Bonello William | officer: President, Informatics | 10,727 | M-Exempt | D | 25,000 | 7.52 | 188,000.00 |
| 2021-11-30 | Bonello William | officer: President, Informatics | 40,473 | M-Exempt | A | 25,000 | 7.52 | 188,000.00 |
| 2021-11-26 | Brown Douglas Matthew | officer: Chief Strategy Officer | 11,644 | S-Sale | D | 33,334 | 36.85 | 1,228,357.90 |
| 2021-11-24 | Bonello William | officer: President, Informatics | 45,370 | M-Exempt | D | 25,000 | 8.03 | 200,750.00 |
| 2021-11-24 | Bonello William | officer: President, Informatics | 15,473 | S-Sale | D | 25,000 | 37.13 | 928,250.00 |
| 2021-11-24 | Bonello William | officer: President, Informatics | 40,473 | M-Exempt | A | 25,000 | 8.03 | 200,750.00 |
| 2021-11-24 | Brown Douglas Matthew | officer: Chief Strategy Officer | 44,978 | S-Sale | D | 33,333 | 36.84 | 1,227,987.72 |
| 2021-11-23 | Brown Douglas Matthew | officer: Chief Strategy Officer | 78,311 | S-Sale | D | 33,333 | 37.19 | 1,239,654.27 |
| 2021-11-10 | Daly David | director | 1,945 | A-Award | A | 1,945 | 43.39 | 84,393.55 |
| 2021-11-10 | Daly David | director | 1,623 | A-Award | A | 1,623 | 0.00 | 0.00 |
| 2021-10-11 | TETRAULT LYNN A. | director | 972 | A-Award | A | 972 | 41.76 | 40,590.72 |
| 2021-10-11 | TETRAULT LYNN A. | director | 35,777 | A-Award | A | 838 | 0.00 | 0.00 |
| 2021-08-17 | Gilbert Halley E | officer: Chief Legal Officer | 63,331 | A-Award | A | 63,331 | 42.21 | 2,673,201.51 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.